adenosine transporter

from a variety of organisms; has been sequenced

Networked: 15 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Carrier Proteins: 12999
    - Membrane Transport Proteins: 589
      - Nucleobase, Nucleoside, Nucleotide, and Nucleic Acid Transport Proteins
        Nucleoside Transport Proteins: 164
        adenosine transporter: 15
  - Membrane Proteins: 10078
    - Membrane Transport Proteins: 589
      - Nucleobase, Nucleoside, Nucleotide, and Nucleic Acid Transport Proteins
        Nucleoside Transport Proteins: 164
        adenosine transporter: 15

Experts

1.	Pastor-Anglada, Marçal: 3 articles (09/2013 - 04/2004)
2.	Nakano, Takashi: 2 articles (08/2012 - 08/2010)
3.	Nishizaki, Tomoyuki: 2 articles (08/2012 - 08/2010)
4.	Parkinson, Fiona E: 2 articles (03/2012 - 08/2005)
5.	Ajam, Firas: 1 article (12/2021)
6.	Al-Bayati, Asseel: 1 article (12/2021)
7.	Apolito, Renato: 1 article (12/2021)
8.	Hansalia, Riple: 1 article (12/2021)
9.	Udongwo, Ndausung: 1 article (12/2021)
10.	Wiseman, Kyle: 1 article (12/2021)

Related Diseases

1.	Glioma (Gliomas) 08/22/2005 - "In uptake studies using cultured rat C6 glioma cells, amitriptyline inhibited adenosine uptake by an adenosine transporter (IC50 0.37 +/- 0.12 mM). "
2.	Ischemia 01/01/2023 - "Extension of these findings implicates adenosine transporter inhibitors in cardioprotection against ischemia and reperfusion injury." 06/17/2014 - "The effect is mediated by inhibition of the adenosine transporter ENT1 (type 1 equilibrative nucleoside transporter), which provides protection for adenosine from intracellular metabolism, thus increasing its concentration and biological activity, particularly at sites of ischemia and tissue injury where it is formed. " 12/01/2021 - "Additionally, ticagrelor inhibits the equilibrative nucleoside transporter 1 adenosine transporter protein leading to an increased concentration of adenosine in the blood, particularly at sites of ischemia. "
3.	Hepatocellular Carcinoma (Hepatoma) 04/01/2004 - "The high-affinity Na(+)-dependent adenosine transporter CNT2 and A(1)R are coexpressed in the basolateral domain of the rat hepatocyte plasma membrane and are colocalized in the rat hepatoma cell line FAO. " 08/01/2010 - "Extracellular adenosine disrupted mitochondrial membrane potentials in HuH-7 cells, a Fas-deficient human hepatoma cell line, and the effect was inhibited by the adenosine transporter inhibitor dipyridamole or by overexpressing Bcl-X(L). "
4.	Hypoxia (Hypoxemia) 09/15/2013 - "Hypoxia and P1 receptor activation regulate the high-affinity concentrative adenosine transporter CNT2 in differentiated neuronal PC12 cells." 03/01/2004 - "Hypoxia regulates the adenosine transporter, mENT1, in the murine cardiomyocyte cell line, HL-1."
5.	Desmoplastic Small Round Cell Tumor 06/04/2008 - "Adenosine transporter ENT4 is a direct target of EWS/WT1 translocation product and is highly expressed in desmoplastic small round cell tumor."

Related Drugs and Biologics

1.	Adenosine (Adenocard)
2.	Amitriptyline (Elavil)
3.	Dipyridamole (Persantine)
4.	Adrenomedullin Receptors
5.	AMP-Activated Protein Kinases
6.	Equilibrative Nucleoside Transporter 1
7.	Nucleoside Transport Proteins (Nucleoside Transporter)
8.	Monocarboxylic Acid Transporters
9.	Endothelin-1 (Endothelin 1)
10.	Purinergic P1 Receptors (Adenosine Receptor)

Related Therapies and Procedures

1.	Therapeutics